Life sciences briefing: Tuesday, Feb. 5, 2008
TODAY’S HEADLINES:
Amira Pharma strikes GSK partnership on lung, heart drugs worth up to $425M (release)
Wolters Kluwer Health takes stake in Logical Images (release)
Gentiva Health acquires Home Health Care Affiliates for $55M (release)
Compuware buys Hilgraeve to upgrade healthcare IT (release)
Touchstone Health appoints Michael Muchnicki CEO (release)
Australia’s Xenome names Ian Nesbit as CEO (release)
Amira Pharma strikes GSK partnership on lung, heart drugs worth up to $425M – Amira Pharmaceuticals, a San Diego biotech focused on drugs for lung… Continue Reading
Brownian motion: Personnel moves in the life sciences
NeurAxon, a Waltham, Mass., biotech developing new pain drugs, named Lawrence Bloch as its new CEO. Bloch was previously chief financial officer of NitroMed, a company best known for BiDil, the first drug approved specifically to treat heart disease in African-Americans. BiDil sales haven’t really taken off, and NitroMed’s stock has fallen considerably since its recent high in February. Bloch left his position at NitroMed almost a year and a half ago.
Amira Pharmaceuticals, a San… Continue Reading